エピソード

  • Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2

    Oncology Nursing Update Special 2-Part Edition: Bispecific Antibodies in Lymphoma — Part 2
    2025/04/18

    Nurse practitioner Ms Amy Goodrich from The Sidney Kimmel Comprehensive Care Center in Baltimore, Maryland, presents cases from her practice illustrating the efficacy and safety of bispecific antibodies for non-Hodkin lymphoma.

    NCPD information and select publications here.
    続きを読む 一部表示
    58 分
  • Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting

    Myelofibrosis — An Interview with Dr Raajit K Rampal on Key Presentations from the 66th American Society of Hematology (ASH) Annual Meeting
    2025/04/15

    Dr Raajit K Rampal from Memorial Sloan Kettering Cancer Center in New York, New York, discusses recent updates on available and novel treatment strategies for myelofibrosis.

    CME information and select publications here.
    続きを読む 一部表示
    43 分
  • Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit

    Chronic Lymphocytic Leukemia — Fourth Annual National General Medical Oncology Summit
    2025/04/12

    Clinical investigators discuss available data guiding the management of chronic lymphocytic leukemia. 

    CME information and select publications here.
    続きを読む 一部表示
    50 分
  • Chronic Lymphocytic Leukemia — An Interview with Dr Catherine C Coombs on Real-World Cases and Current Questions and Controversies Presented at Recent Conferences

    Chronic Lymphocytic Leukemia — An Interview with Dr Catherine C Coombs on Real-World Cases and Current Questions and Controversies Presented at Recent Conferences
    2025/04/04

    Dr Catherine C Coombs from UCI Health in Orange County, California, discusses patient cases from her practice and provides an overview of existing and emerging treatment approaches for chronic lymphocytic leukemia.

    CME information and select publications here.

    続きを読む 一部表示
    58 分
  • Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards for Oncology Nurses

    Bispecific Antibodies in Multiple Myeloma — An Interview with Dr Tiffany A Richards for Oncology Nurses
    2025/03/24

    Dr Tiffany Richards from The University of Texas MD Anderson Cancer Center in Houston discusses the current and emerging role of bispecific antibodies in the treatment of multiple myeloma.

    NCPD information and select publications here.

    続きを読む 一部表示
    1 時間 5 分
  • Bispecific Antibodies in Lymphoma Part 1 — An Interview with Ms Robin Klebig for Oncology Nurses

    Bispecific Antibodies in Lymphoma Part 1 — An Interview with Ms Robin Klebig for Oncology Nurses
    2025/03/18

    Ms Robin Klebig from the Mayo Clinic in Rochester, Minnesota, discusses the emerging role of bispecific antibodies in the treatment of non-Hodgkin lymphoma.

    NCPD information and select publications here.
    続きを読む 一部表示
    1 時間 6 分
  • Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies

    Relapsed/Refractory Diffuse Large B-Cell Lymphoma — A Roundtable Discussion on Current and Future Management Strategies
    2025/02/25

    Prof Martin Hutchings from Copenhagen University Hospital in Denmark, Dr Manali Kamdar from the University of Colorado Cancer Center, Dr Matthew Lunning from the University of Nebraska Medical Center and Prof Gilles Salles from Memorial Sloan Kettering Cancer Center in New York summarize currently available data guiding treatment decision-making for patients with relapsed/refractory diffuse large B-cell lymphoma and present cases from their practices.

    CME information and select publications here.
    続きを読む 一部表示
    2 時間 33 分
  • Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy

    Multiple Myeloma — An Interview with Dr Surbhi Sidana on Optimizing the Role of CAR T-Cell Therapy
    2025/02/19

    Dr Surbhi Sidana from Stanford University in California discusses recent updates on chimeric antigen receptor T-cell therapy for the treatment of multiple myeloma.

    CME information and select publications here.
    続きを読む 一部表示
    47 分